Profile data is unavailable for this security.
About the company
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
- Revenue in CHF (TTM)43.89bn
- Net income in CHF6.29bn
- LocationNovartis AGLichtstrasse 35BASEL 4056SwitzerlandCHE
- Phone+41 613241111
- Fax+41 613247826
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|NOVN:SWX since |
|Cadent Therapeutics||Announced||17 Dec 2020||17 Dec 2020Announced||6.16%||770.00m|
|Vedere Bio Inc||Deal completed||30 Sep 2020||30 Sep 2020Deal completed||6.19%||280.00m|
|Amblyotech Inc||Deal completed||20 Apr 2020||20 Apr 2020Deal completed||-0.60%||--|